Market Research Logo

Celldex Therapeutics, Inc. (formerly AVANT Immunotherapeutics, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

COMPANY OVERVIEW AND KEY FACTS
Mergers and Acquisitions – Deal reports
Corporate Venturing – Deal reports
PARTNERSHIP
Partnership – Overview
Partnership – Deal reports
CAPITAL RAISING
Capital Raising – Overview
Capital Raising – Deal reports
Divestments – Deal reports
APPENDIX
About Datamonitor Financial Deals Database
Deal Definition and Methodology
About Datamonitor
Datamonitor Professional Services Knowledge Center
LIST OF TABLES
Celldex Therapeutics activity by deal type – volume (2014-TTM2015)
Celldex Therapeutics activity by deal type – volume (2011 -YTD2015)
Celldex Therapeutics legal advisor ranking by value ($m)
Celldex Therapeutics financial advisor ranking by value ($m)
Top Deals(2011 -YTD2015)
Celldex Therapeutics targets and partners (2011 -YTD2015)
Celldex Therapeutics partnership volume and value trend (2011-YTD2015)
Celldex Therapeutics partnership trend by key deal type (2011-YTD2015)
Celldex Therapeutics capital raising volume and value trend (2011-YTD2015)
Celldex Therapeutics capital raising by deal type (2011-YTD2015)
LIST OF FIGURES
Celldex Therapeutics activity by deal type - volume (trailing twelve months (TTM))
Celldex Therapeutics activity by deal type - volume (2011-YTD2015)
Celldex Therapeutics partnership volume and value trend (2011-YTD2015)
Celldex Therapeutics partnership trend by key deal type (2011-YTD2015)
Celldex Therapeutics capital raising volume and value trend (2011-YTD2015)
Celldex Therapeutics capital raising by deal type (2011-YTD2015)

Project Synopsis:

Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Project Description:

Datamonitors' Celldex Therapeutics, Inc. (formerly AVANT Immunotherapeutics, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Celldex Therapeutics, Inc. (formerly AVANT Immunotherapeutics, Inc.) since January 2007.

Scope:

  • Provides intelligence on Celldex Therapeutics, Inc. (formerly AVANT Immunotherapeutics, Inc.)'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
  • Detailed reports of various financial transactions undertaken by Celldex Therapeutics, Inc. (formerly AVANT Immunotherapeutics, Inc.) and its subsidiaries since 2007.
  • Information about key financial and legal advisors for Celldex Therapeutics, Inc. (formerly AVANT Immunotherapeutics, Inc.)'s financial deals transactions.
  • Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Highlights:

This report includes Celldex Therapeutics, Inc. (formerly AVANT Immunotherapeutics, Inc.)'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Celldex Therapeutics, Inc. (formerly AVANT Immunotherapeutics, Inc.). These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Reasons to Purchase:
  • Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
  • Form an independent opinion about Celldex Therapeutics, Inc. (formerly AVANT Immunotherapeutics, Inc.)’s growth strategies through the organic and inorganic activities undertaken since 2007.
  • Track your competitors’ business structure and growth strategies.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;